Edit |   |
---|---|
Antigenic Specificity | APP Abeta, Human (Bapineuzumab biosimilar) |
Clone | Bapineuzumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | WB, FuncS, IF, Neut, ELISA, FCM, IP |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human APP Abeta Recombinant Antibody (Bapineuzumab). Bapineuzumab (nicknamed "bapi") is a humanized monoclonal antibody that acts on the nervous system and may have potential therapeutic value for the treatment of Alzheimer's disease and possibly glaucoma. However, in 2012 it failed to produce significant cognitive improvements in patients in two major trials, despite lowering key biomarkers of AD, amyloid brain plaque and hyperphosphorylated tau protein in CSF. |
Immunogen | n/a |
Other Names | Anti-APP Abeta Recombinant Antibody, Research Grade Bapineuzumab, Anti-Human APP Abeta Recombinant Antibody(Bapineuzumab), AAB-001, Antibody Drug Analogues, Monoclonal Antibody, YR1164, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 648895-38-9 |
Catalog # | YR1164 |
Price | please inquire |
Order / More Info | APP Abeta, Human (Bapineuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |